Oncology Molecular Diagnostics Market: By Type, By Product, By Test Location, By Technology, Chips & Microarrays, Chips & Microarrays, Sequencing, Transcription Mediated Amplification, Others) and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Oncology Molecular Diagnostics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Others), By Product (Instruments, Reagents, Others), By Test Location ( Clinics and Other Establishments, Others), By Technology ( PCR, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Chips & Microarrays, Chips & Microarrays, Sequencing, Transcription Mediated Amplification, Others) and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Oncology Molecular Diagnostics Market size was valued at US$ 3.63 billion in 2023 and expected to reach a value of US$ 8.32 billion by 2030, growing at a CAGR of 12.6% from 2024-2030. The global market provides a detailed overview of the market and that can be segmented by type, product, test location, and technology. By type, The market has been segmented into Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, and Others.

The Brest cancer segment is likely to be the largest and fastest-growing segment in terms of type. Based on product the market is segmented into Instruments, Reagents, and Others. Among these, the reagents segment is expected to have the fastest-growing market during the forecast period 2023-2029. Based on the test location, the market is segmented into Clinics and Other Establishments, Others. The clinic segment accounts for the largest share in 2022.  

Key Development

  • In February 2020, Danaher (Cepheid) announced a collaboration with Sherlock Biosciences to explore the innovative, ground-breaking molecular diagnostic test development intended for oncology and infectious diseases deploying CRISPR technology.

summary download arrow Download Free Sample

Oncology Molecular Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

12.6%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Oncology Molecular Diagnostics Market Dynamics

Increase in the prevalence of cancers such as breast cancer in women and prostate cancer is men is the major factor anticipated to burgeon the market over the forecast years. Moreover, rise in R&D for the development of point of care diagnostic test kits, government initiatives for the cancer screening programs, and the launch of advanced test kits are immense boost to the market over the forecast timeframe.

Oncology Molecular Diagnostics Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 3.63 billion

Market Size in 2030

US$ 8.32 billion

Market CAGR

12.6%

By Type

  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Liver Cancer
  • Lung Cancer
  • Blood Cancer
  • Kidney Cancer
  • Others

By Product Type

  • Instruments
  • Reagents
  • Others

By Technology

  • PCR
  • In Situ Hybridization
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Chips & Microarrays
  • Chips & Microarrays
  • Sequencing
  • Transcription Mediated Amplification
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The oncology molecular diagnostics market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis 

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

Oncology molecular diagnostics market size was valued at US$ 3.63 billion in 2023 and is set to reach US$ 8.32 billion by 2030 at a CAGR of 12.6% from 2024-2030

The major players in the market are Abbott Laboratories, Bayer Healthcare AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Cepheid, Inc., Danaher Corporation, Hologic, Inc., Leica Biosystems Inc., Qiagen NV, Roche Diagnostics (Schweiz) AG, Siemens Healthineers, Sysmex Corporation

Asia-Pacific is the fastest-growing region for the market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Oncology Molecular Diagnostics Market Introduction
2.1. Global Oncology Molecular Diagnostics Market - Taxonomy
2.2. Global Oncology Molecular Diagnostics Market -Definitions
2.2.1. By Type
2.2.2. By Product
2.2.3. By Test Location
2.2.4. By Technology
2.2.5. By Region
3. Global Oncology Molecular Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Oncology Molecular Diagnostics Market Dynamic Factors - Impact Analysis
3.6. Global Oncology Molecular Diagnostics Market - Competition Landscape
3.7. Epidemiology Data
4. Global Oncology Molecular Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Oncology Molecular Diagnostics Market, By Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1. Breast Cancer
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Prostate Cancer
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Colorectal Cancer
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Cervical Cancer
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Liver Cancer
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Lung Cancer
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Blood Cancer
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Kidney Cancer
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Others
5.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
6. Global Oncology Molecular Diagnostics Market, By Product, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1. Instruments
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Reagents
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Others
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Oncology Molecular Diagnostics Market, By Test Location, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1. Clinics and Other Establishments
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Others
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Oncology Molecular Diagnostics Market, By Technology, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1. PCR
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. In Situ Hybridization
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Chips & Microarrays
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Mass Spectroscopy
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Sequencing
8.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.6.3. Market Opportunity Analysis
8.7. Transcription Mediated Amplification
8.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.7.3. Market Opportunity Analysis
8.8. Others
8.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.8.3. Market Opportunity Analysis
9. Global Oncology Molecular Diagnostics Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Oncology Molecular Diagnostics Market - Opportunity Analysis Index, By Type, By Resin, By Application, and Region, 2024 - 2030
10. North America Oncology Molecular Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
10.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Breast cancer
10.1.2. Prostate cancer
10.1.3. Colorectal cancer
10.1.4. Cervical cancer
10.1.5. Liver cancer
10.1.6. Lung cancer
10.1.7. Blood cancer
10.1.8. Kidney cancer
10.1.9. Others
10.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Instruments
10.2.2. Reagents
10.2.3. Others
10.3. Test Location Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Clinics and other establishments
10.3.2. Point of Care
10.4. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. PCR
10.4.1.1. Multiplex
10.4.1.2. Others
10.4.2. In Situ Hybridization
10.4.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
10.4.4. Chips and microarrays
10.4.5. Mass spectrometry
10.4.6. Sequencing
10.4.7. Transcription Mediated Amplification
10.4.8. Others
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Oncology Molecular Diagnostics Market - Opportunity Analysis Index, By Type, Product, Test Location, Technology, And Country, 2024 - 2030
10.7. North America Oncology Molecular Diagnostics Market Dynamics - Trends
11. Europe Oncology Molecular Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
11.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Breast cancer
11.1.2. Prostate cancer
11.1.3. Colorectal cancer
11.1.4. Cervical cancer
11.1.5. Liver cancer
11.1.6. Lung cancer
11.1.7. Blood cancer
11.1.8. Kidney cancer
11.1.9. Others
11.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Instruments
11.2.2. Reagents
11.2.3. Others
11.3. Test Location Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Clinics and other establishments
11.3.2. Point of Care
11.4. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. PCR
11.4.1.1. Multiplex
11.4.1.2. Others
11.4.2. In Situ Hybridization
11.4.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
11.4.4. Chips and microarrays
11.4.5. Mass spectrometry
11.4.6. Sequencing
11.4.7. Transcription Mediated Amplification
11.4.8. Others
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Oncology Molecular Diagnostics Market - Opportunity Analysis Index, By Type, Product, Test Location, Technology, And Country, 2024 - 2030
11.7. Europe Oncology Molecular Diagnostics Market Dynamics - Trends
12. Asia-Pacific Oncology Molecular Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
12.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Breast cancer
12.1.2. Prostate cancer
12.1.3. Colorectal cancer
12.1.4. Cervical cancer
12.1.5. Liver cancer
12.1.6. Lung cancer
12.1.7. Blood cancer
12.1.8. Kidney cancer
12.1.9. Others
12.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Instruments
12.2.2. Reagents
12.2.3. Others
12.3. Test Location Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Clinics and other establishments
12.3.2. Point of Care
12.4. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. PCR
12.4.1.1. Multiplex
12.4.1.2. Others
12.4.2. In Situ Hybridization
12.4.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
12.4.4. Chips and microarrays
12.4.5. Mass spectrometry
12.4.6. Sequencing
12.4.7. Transcription Mediated Amplification
12.4.8. Others
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Oncology Molecular Diagnostics Market - Opportunity Analysis Index, By Type, Product, Test Location, Technology, And Country, 2024 - 2030
12.7. Asia-Pacific Oncology Molecular Diagnostics Market Dynamics - Trends
13. Latin America Oncology Molecular Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2020 - 2026
13.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Breast cancer
13.1.2. Prostate cancer
13.1.3. Colorectal cancer
13.1.4. Cervical cancer
13.1.5. Liver cancer
13.1.6. Lung cancer
13.1.7. Blood cancer
13.1.8. Kidney cancer
13.1.9. Others
13.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Instruments
13.2.2. Reagents
13.2.3. Others
13.3. Test Location Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Clinics and other establishments
13.3.2. Point of Care
13.4. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. PCR
13.4.1.1. Multiplex
13.4.1.2. Others
13.4.2. In Situ Hybridization
13.4.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
13.4.4. Chips and microarrays
13.4.5. Mass spectrometry
13.4.6. Sequencing
13.4.7. Transcription Mediated Amplification
13.4.8. Others
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Oncology Molecular Diagnostics Market - Opportunity Analysis Index, By Type, Product, Test Location, Technology, And Country, 2024 - 2030
13.7. Latin America Oncology Molecular Diagnostics Market Dynamics - Trends
14. Middle East and Africa Oncology Molecular Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
14.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Breast cancer
14.1.2. Prostate cancer
14.1.3. Colorectal cancer
14.1.4. Cervical cancer
14.1.5. Liver cancer
14.1.6. Lung cancer
14.1.7. Blood cancer
14.1.8. Kidney cancer
14.1.9. Others
14.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Instruments
14.2.2. Reagents
14.2.3. Others
14.3. Test Location Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Clinics and other establishments
14.3.2. Point of Care
14.4. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. PCR
14.4.1.1. Multiplex
14.4.1.2. Others
14.4.2. In Situ Hybridization
14.4.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
14.4.4. Chips and microarrays
14.4.5. Mass spectrometry
14.4.6. Sequencing
14.4.7. Transcription Mediated Amplification
14.4.8. Others
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Oncology Molecular Diagnostics Market - Opportunity Analysis Index, By Type, Product, Test Location, Technology, And Country, 2024 - 2030
14.7. MEA Oncology Molecular Diagnostics Market Dynamics - Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.1.1. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
15.1.2. Abbott Laboratories
15.1.3. Bayer Healthcare AG
15.1.4. Beckman Coulter, Inc.
15.1.5. Becton, Dickinson and Company
15.1.6. Cepheid, Inc.
15.1.7. Danaher Corporation
15.1.8. Hologic, Inc.
15.1.9. Leica Biosystems Inc.
15.1.10. Qiagen NV
15.1.11. Roche Diagnostics (Schweiz) AG
15.1.12. Siemens Healthineers
15.1.13. Sysmex Corporation
16. Research Methodology
17. Key Assumptions and Acronyms

Key Market Players

  • Abbott Laboratories
  • Bayer Healthcare AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Cepheid, Inc.
  • Danaher Corporation
  • Hologic, Inc.
  • Leica Biosystems Inc.
  • Qiagen NV
  • Roche Diagnostics (Schweiz) AG
  • Siemens Healthineers
  • Sysmex Corporation

Related Industry Reports

Global Breast Cancer Treatment Market

Global Prostate Cancer Therapeutics Market